ReviewActa pharmacologica Sinica2026

Rebalancing the inflammatory trajectory from inflammatory bowel disease to colitis-associated colorectal cancer via artemisinin-based multitarget therapy.

Shi-Jun He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.